Archives
-
FLAG tag Peptide: Smarter Protein Purification
2026-10-01
The FLAG tag Peptide (DYKDDDDK) combines highly specific epitope recognition with gentle competitive elution, making it useful for recombinant protein purification, detection, and interaction assays. This workflow shows how to deploy it effectively in chromatin-complex studies inspired by the Sin3L/Rpd3L HDAC research while avoiding common tag-accessibility and elution failures.
-
3X FLAG Peptide: Practical Protein Workflows
2026-09-30
The 3X (DYKDDDDK) Peptide supports sensitive FLAG fusion detection, competitive elution, and structural biology workflows without requiring a large protein tag. This guide connects its practical use to non-canonical microprotein validation, with protocol starting points and troubleshooting for antibody, metal, and storage variables.
-
Spleen-Targeted Neoantigen mRNA Vaccine in HCC
2026-09-30
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that generated ISG15-positive CD8-positive T cells and promoted tertiary lymphoid structure formation in hepatocellular carcinoma. The study connects organ-selective delivery with GZMA-F2R signaling between cytotoxic T cells and antigen-presenting cells, while also defining practical considerations for reproducible mRNA preparation.
-
Levofloxacin Workflows for Resistance and Bone Assays
2026-09-29
Build mechanism-led bacterial susceptibility, plasmid-transfer, osteoblast, and cartilage assays with Levofloxacin (SKU B1959). This guide connects resistance surveillance to quantitative bone-cell readouts while emphasizing solubility control, orthogonal endpoints, and troubleshooting.
-
Anti-DYKDDDDK (Flag) Magnetic Beads Workflow
2026-09-29
Anti-DYKDDDDK (Flag) Magnetic Beads selectively capture DYKDDDDK-tagged fusion proteins from lysates and other complex samples for small-scale purification, immunoprecipitation, and co-immunoprecipitation. They are intended for accessible Flag-tagged targets, not for tag-free proteins, general protein enrichment, or unvalidated high-throughput workflows.
-
BOP Reagent for Peptide Prodrug Workflows
2026-09-28
BOP reagent provides a practical route for carboxyl group activation, direct amide bond formation, and phenyl ester preparation in modular peptide and prodrug synthesis. This guide translates that chemistry into assay-ready workflows inspired by a carrier-free, ROS-responsive OSCC prodrug study while clearly separating established specifications from optimization starting points.
-
Gastrin I: Linking Acid Secretion to GI Models
2026-09-28
Gastrin I (human) offers a defined way to probe CCK2-receptor-linked gastric acid secretion. This article explains how to use it in a compartment-aware research strategy alongside human intestinal organoids—without conflating gastric physiology with intestinal pharmacokinetics.
-
Lactate-Driven HMGB1 Modification in Sepsis
2026-09-27
The study links elevated lactate to HMGB1 lactylation and acetylation in macrophages, followed by exosomal release that can increase endothelial permeability. Its findings identify lactate-associated signaling as a candidate mechanism in polymicrobial sepsis, while leaving important questions about clinical translation and treatment specificity.
-
Azathramycin A: Ribosome Assays for TB Research
2026-09-26
Use Azathramycin A to investigate ribosome binding and bacterial protein synthesis inhibition in tuberculosis-focused research—not as a clinical treatment recommendation. This workflow pairs target-level assays with cautious cell-based follow-up, while accounting for solvent limits, solution instability, and the gap between a piglet PK/PD study and Mycobacterium tuberculosis research.
-
Cy3-UTP for RNA Delivery Assay Design
2026-09-25
Cy3-UTP can make RNA visible, but fluorescence alone cannot explain why a delivery system succeeds or fails. This article connects fluorescent RNA labeling to evidence on lipid nanoparticle surface charge and cellular V-ATPase activity, with practical guidance for separating uptake, intracellular processing, and RNA function.
-
Praeruptorin A Limits HCC Invasion Through ERK/MMP1
2026-09-25
A cell-based study found that praeruptorin A (PA) reduced migration and invasion in three human hepatocellular carcinoma cell lines without detectable cytotoxicity or cell-cycle changes. ERK knockdown reversed PA-associated MMP1 suppression and restored invasive behavior, supporting an ERK-dependent antimetastatic mechanism that remains to be tested in animal models and clinical settings.
-
FLAG tag Peptide for Native Membrane Complexes
2026-09-24
Learn how the FLAG tag Peptide (DYKDDDDK) can support isolation and analysis of native membrane-protein assemblies. A recent FtsH–HflK/C structural study shows why tag design, expression context, and gentle elution matter when interpreting complex architecture.
-
BRAF–NMDAR Signaling Drives Neuropathic Pain
2026-09-24
A 2026 study identifies BRAF in sensory neurons as a regulator of spinal NMDAR phosphorylation and synaptic hyperactivity after nerve injury. The results connect BRAF pathway activity to persistent pain behavior and suggest a potential therapeutic direction, while leaving clinical efficacy and the detailed signaling sequence to be established.
-
Bardoxolone methyl in Redox Assay Workflows
2026-09-23
Use Bardoxolone methyl to probe Nrf2 activation and NF-kB suppression, then pair pathway readouts with redox-sensitive replication-stress assays. This workflow distinguishes verified target engagement from a testable—but not yet established—effect on thioredoxin, ribonucleotide reductase, and CHK1-inhibitor response.
-
Fast-Dissociating Antibodies by Single-Molecule Screening
2026-09-23
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes supported multiplex super-resolution imaging and revealed rapid espin turnover within the long-lived F-actin cores of inner-ear stereocilia.